ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
소태아혈청 시장 규모는 향후 몇 년동안 강력한 성장을 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 5.7%로 13억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 세포치료의 채택 증가, 첨단 치료법의 출현, 동물대체요법에 대한 관심, 공급업체와 고객 간의 전략적 관계 등에 기인합니다. 예측 기간 동안 세계 동향으로는 품질 및 추적성 중시, 세계 협력 및 파트너십, 전략적 M&&A, 맞춤형 소태아혈청 제품, 규제 준수, 윤리적 조달 등이 있습니다.
바이오 의약품에 대한 수요 급증은 예측 기간 동안 소태아혈청(FBS) 시장 성장의 중요한 촉진제가 될 것으로 예상됩니다. 바이오의약품은 동물, 인간, 미생물 등 생물체에서 유래한 의약품으로, 그 제조에는 생명공학 기술이 사용됩니다. 소태아혈청은 동물 세포 배양 배지의 대체제로 가장 널리 이용되고 있으며, 이 과정에서 중요한 역할을 하고 있습니다. 제약회사, 진단 실험실 및 연구자들은 생물학적 제제 연구에서 세포 배양 요건을 충족하기 위해 FBS에 크게 의존하고 있으며, 영국의 생명과학 서비스 및 컨설팅 회사인 Proclinical Limited는 2022년 의약품 및 백신 부문에서 전년 대비 11% 증가한 3 615만 달러의 주목할 만한 매출을 기록했습니다. 이 실적은 바이오 의약품 관련 제품 및 서비스에 대한 수요가 증가하고 있음을 입증합니다. 그 결과, 바이오 의약품에 대한 수요 증가는 소태아혈청 시장의 성장을 가속하는 중요한 요인이 되고 있습니다.
예상되는 백신 생산 증가는 예측 기간 동안 소태아혈청(FBS) 시장의 성장을 가속할 것으로 예상됩니다. 백신은 특정 감염성 질환에 대한 능동적 획득 면역을 부여하기 위해 고안된 생물학적 제제입니다. 소태아혈청은 일반적으로 백신 제조에서 세포 배양 배지로 사용되어 제조 공정에 관여하는 세포의 성장을 지원하며, FBS는 특정 세포주 배양에 필요한 필수 영양소, 성장 인자, 호르몬을 공급하고 백신을 구성하는 바이러스 및 항원의 효율적인 복제를 촉진합니다. 예를 들어, 2021년 9월 스위스에 본부를 둔 업계 단체인 국제제약협회(IFPMA)는 백신 제조업체들이 매월 15억 회 분량의 백신을 생산하고 있으며, 2021년 말까지 120억 회 분량, 2022년 6월까지 240억 회 분량에 달할 것으로 예측하여 전 세계 수요를 초과할 수 있다고 보고했습니다. 라고 합니다. 따라서 백신 생산량 증가가 소태아혈청 시장의 성장을 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계소태아혈청 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업 분석
세계의 소태아혈청 시장 : 성장률 분석
세계의 소태아혈청 시장 실적 : 규모와 성장, 2019-2024
세계의 소태아혈청 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계소태아혈청 TAM(Total Addressable Market)
제6장 시장 세분화
세계의 소태아혈청 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
숯 제거
크로마토그래피
투석된 소태아혈청
엑소좀 고갈
줄기세포
기타 제품
세계의 소태아혈청 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
Drug Discovery
세포배양 배지
체외수정
인간 및 동물 백신 제조
진단
기타 용도
세계의 소태아혈청 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
연구 및 학술기관
바이오테크놀러지 및 제약 업계
기타 최종사용자
세계의 소태아혈청 시장 : 탄화물별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
표준탄 제거 FBS
가열 불활성탄 처리 FBS
세계의 소태아혈청 시장 : 크로마토그래피별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
이온 교환 크로마토그래피 정제 FBS
어피니티 크로마토그래피 정제 FBS
세계의 소태아혈청 시장 : 투석 소태아혈청 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
표준 투석 FBS
가열 불활성화 투석 FBS
세계의 소태아혈청 시장 : 엑소좀 제거 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
표준 엑소좀 제거 FBS
가열 불활성화 엑소좀 제거 FBS
세계의 소태아혈청 시장 : 줄기세포별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
줄기세포 등급 FBS
녹아웃 혈청 대체품
세계의 소태아혈청 시장 : 기타 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
특정 동물종 혈청
커스텀 처리 FBS
제7장 지역별/국가별 분석
세계의 소태아혈청 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 소태아혈청 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
소태아혈청 시장 : 경쟁 구도
소태아혈청 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
Cytiva Overview, Products and Services, Strategy and Financial Analysis
VWR International Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
Sartorius AG
Bio-Techne Corporation
Atlas Biologicals Inc.
R&D Systems Inc.
Atlanta Biologicals Inc.
Cyagen Biosciences
GenClone Inc.
Gemini Bio-Products
Access Biologicals LLC
Nucleus Biologics
ZenBio Inc.
Biowest
Bovogen Biologicals Pty Ltd.
TCS Biosciences Ltd.
J R Scientific Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
소태아혈청 시장(2029년) : 새로운 기회를 제공하는 국가
소태아혈청 시장(2029년) : 새로운 기회를 제공하는 부문
소태아혈청 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Fetal bovine serum is a crucial component in animal cell culture media used to support the growth of eukaryotic cells cultured in vitro. It is obtained from bovine fetuses harvested from pregnant cows slated for slaughter, often through a cardiac puncture without anesthesia.
The main types of fetal bovine serum include charcoal-stripped, chromatographic, dialyzed, exosome-depleted, stem cell, and others. Charcoal-stripped fetal bovine serum contains activated carbon that helps reduce levels of lipophilic compounds such as hormones, growth factors, and steroids. It is commonly used in studies related to receptors or estrogen. Dialyzed fetal bovine serum has a reduced concentration of low molecular weight components, such as nucleotides, amino acids, hormones, salts, and small proteins, making it suitable for cell culture systems that require a more defined environment of small molecules. Exosome-depleted fetal bovine serum is designed to isolate exosomes from cultured cells without the presence of bovine exosomes found in conventional fetal bovine serum. This type is often used for research on exosomes. Fetal bovine serum finds applications in various areas, including drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, and more. The usage of fetal bovine serum spans across different sectors, including research and academic institutes, the biotechnology and pharmaceutical industry, and other related fields.
The fetal bovine serum market research report is one of a series of new reports from The Business Research Company that provides fetal bovine serum market statistics, including fetal bovine serum industry global market size, regional shares, competitors with a fetal bovine serum market share, detailed fetal bovine serum market segments, market trends and opportunities, and any further data you may need to thrive in the fetal bovine serum industry. This fetal bovine serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fetal bovine serum market size has grown strongly in recent years. It will grow from $1.02 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to expansion of biopharmaceutical industry, rise in cell-based therapies, quality and consistency requirements.
The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1.34 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing adoption of cell therapies, emergence of advanced therapeutics, focus on animal-free alternatives, strategic supplier-customer relationships. Major trends in the forecast period include focus on quality and traceability, global collaboration and partnerships, strategic mergers and acquisitions, customized fetal bovine serum products, regulatory compliance and ethical sourcing.
The anticipated surge in demand for biopharmaceuticals is poised to be a significant driver for the growth of the fetal bovine serum (FBS) market in the forecast period. Biopharmaceuticals are medicinal products derived from biological sources such as animals, humans, and microorganisms, employing biotechnology in their production. Fetal bovine serum, being the most widely utilized substitute for animal cell culture media, plays a crucial role in this process. Pharmaceutical companies, diagnostic laboratories, and researchers heavily depend on FBS to meet their cell culture requirements in biologics research. In 2022, ProClinical Limited, a UK-based life sciences service and consulting company, reported notable sales in the pharmaceuticals and vaccines segments, amounting to US$36.15 million, reflecting an 11% year-over-year increase. This financial performance underscores the growing demand for products and services related to biopharmaceuticals. Consequently, the escalating need for biopharmaceuticals is a key factor driving the growth of the fetal bovine serum market.
The anticipated rise in vaccine production is expected to stimulate the growth of the fetal bovine serum (FBS) market during the forecast period. A vaccine is a biological agent designed to confer active, acquired immunity against specific infectious diseases. Fetal bovine serum is commonly used as a cell culture medium in vaccine production, supporting the growth of the cells involved in the manufacturing process. FBS supplies essential nutrients, growth factors, and hormones required for cultivating specific cell lines, thereby facilitating the efficient replication of the virus or antigen that constitutes the vaccine. For example, in September 2021, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a trade association based in Switzerland, reported that vaccine manufacturers were producing 1.5 billion doses monthly, with projections to reach 12 billion by the end of 2021 and 24 billion by June 2022, potentially exceeding global demand. Hence, the increase in vaccine production is driving the growth of the fetal bovine serum market.
The fetal bovine serum market is witnessing a prominent trend marked by the growing number of collaborations between companies and research institutions. Major industry players are entering into partnerships to enhance production capabilities, expand market share, and foster the development of innovative products. A case in point is the collaboration between the US-based GE Healthcare and the New Zealand-based Oritain. In this collaboration, GE Healthcare and Oritain are working together to create an independent test capable of confirming the country of origin of fetal bovine serum (FBS). This development is particularly significant for biomanufacturing entities, as FBS sourced from different countries may present varying levels of risk for virus contamination. By establishing a reliable method to verify the origin of FBS, this collaboration aims to provide valuable assistance to biomanufacturing entities in ensuring the safety and quality of FBS used in diverse countries.
Sartorius, a German-based life science research and biopharmaceutical company acquired Biological Industries for $53.67 million. Through this acquisition, Sartorius expanded cell culture media and complementing the product portfolio for the users in the growing advanced therapies market in the majority portion of Biological Industries. Biological Industries is an Israel-based chemical and biotechnology company that provides fetal bovine serum for mammalian cell culture.
North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the fetal bovine serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fetal bovine serum market consists of sales of Ultra-low IgG, ES Cell, MSC and Exosome-Depleted. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fetal Bovine Serum Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fetal bovine serum market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for fetal bovine serum ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fetal bovine serum market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Charcoal Stripped; Chromatographic; Dialyzed Fetal Bovine Serum; Exosome Depleted; Stem Cell; Other Products
2) By Application: Drug Discovery; Cell Culture Media; In Vitro Fertilization; Human And Animal Vaccine Production; Diagnostics; Other Applications
3) By End-User: Research And Academic Institutes; Biotechnology And Pharmaceutical Industry; Other End-Users
Subsegments:
1) By Charcoal Stripped: Standard Charcoal Stripped FBS; Heat-Inactivated Charcoal Stripped FBS
2) By Chromatographic: Ion Exchange Chromatography Purified FBS; Affinity Chromatography Purified FBS
3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS; Heat-Inactivated Dialyzed FBS
4) By Exosome Depleted: Standard Exosome Depleted FBS; Heat-Inactivated Exosome Depleted FBS
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Fetal Bovine Serum Market Characteristics
3. Fetal Bovine Serum Market Trends And Strategies
4. Fetal Bovine Serum Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Fetal Bovine Serum Growth Analysis And Strategic Analysis Framework
5.1. Global Fetal Bovine Serum PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fetal Bovine Serum Market Growth Rate Analysis
5.4. Global Fetal Bovine Serum Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fetal Bovine Serum Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fetal Bovine Serum Total Addressable Market (TAM)
6. Fetal Bovine Serum Market Segmentation
6.1. Global Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Charcoal Stripped
Chromatographic
Dialyzed Fetal Bovine Serum
Exosome Depleted
Stem Cell
Other Products
6.2. Global Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery
Cell Culture Media
In Vitro Fertilization
Human And Animal Vaccine Production
Diagnostics
Other Applications
6.3. Global Fetal Bovine Serum Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research And Academic Institutes
Biotechnology And Pharmaceutical Industry
Other End-Users
6.4. Global Fetal Bovine Serum Market, Sub-Segmentation Of Charcoal Stripped, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Charcoal Stripped FBS
Heat-Inactivated Charcoal Stripped FBS
6.5. Global Fetal Bovine Serum Market, Sub-Segmentation Of Chromatographic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ion Exchange Chromatography Purified FBS
Affinity Chromatography Purified FBS
6.6. Global Fetal Bovine Serum Market, Sub-Segmentation Of Dialyzed Fetal Bovine Serum, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Dialyzed FBS
Heat-Inactivated Dialyzed FBS
6.7. Global Fetal Bovine Serum Market, Sub-Segmentation Of Exosome Depleted, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Exosome Depleted FBS
Heat-Inactivated Exosome Depleted FBS
6.8. Global Fetal Bovine Serum Market, Sub-Segmentation Of Stem Cell, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Grade FBS
Knockout Serum Replacement
6.9. Global Fetal Bovine Serum Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum from Specific Animal Breeds
Custom-Processed FBS
7. Fetal Bovine Serum Market Regional And Country Analysis
7.1. Global Fetal Bovine Serum Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fetal Bovine Serum Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
